Sign In

Login

Password

Forgot Password ? Sign Up

Tiacetazone (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tiacetazone" in Italian language version.

refsWebsite
Global rank Italian rank
22nih.gov
4th place
9th place
3oadoi.org
799th place
22nd place
3doi.org
2nd place
7th place

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • A. Alahari, X. Trivelli; Y. Guérardel; LG. Dover; GS. Besra; JC. Sacchettini; RC. Reynolds; GD. Coxon; L. Kremer, Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria., in PLoS One, vol. 2, n. 12, 2007, pp. e1343, DOI:10.1371/journal.pone.0001343, PMID 18094751.
  • GA. Ellard, JM. Dickinson; PT. Gammon; DA. Mitchison, Serum concentrations and antituberculosis activity of thiacetazone., in Tubercle, vol. 55, n. 1, Mar 1974, pp. 41-54, PMID 4143449.
  • MJ. Colston, GR. Hilson; RD. Lancaster, Intermittent chemotherapy of experimental leprosy in mice., in Am J Trop Med Hyg, vol. 29, n. 1, Gen 1980, pp. 103-8, PMID 6153254.
  • CA. Peloquin, AT. Nitta; SE. Berning; MD. Iseman; GT. James, Pharmacokinetic evaluation of thiacetazone., in Pharmacotherapy, vol. 16, n. 5, pp. 735-41, PMID 8888068.
  • PJ. Jenner, GA. Ellard; OB. Swai, A study of thiacetazone blood levels and urinary excretion in man, using high performance liquid chromatography., in Lepr Rev, vol. 55, n. 2, Giu 1984, pp. 121-8, PMID 6205236.
  • MR. Holdiness, Clinical pharmacokinetics of the antituberculosis drugs., in Clin Pharmacokinet, vol. 9, n. 6, pp. 511-44, DOI:10.2165/00003088-198409060-00003, PMID 6391781.
  • CA. Pearson, Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria., in J Trop Med Hyg, vol. 81, n. 12, Dic 1978, pp. 238-42, PMID 85717.
  • TR. Bedi, OP. Singh; LK. Bhutani, Acute epidermal necrolysis (Lyell syndrome) induced by thiacetazone., in Indian J Chest Dis, vol. 16, n. 1, Gen 1974, pp. 55-7, PMID 4138214.
  • D. Mame Thierno, S. On; S. Thierno Ndiaye; B. Ndiaye, [Lyell syndrome in Senegal: responsibility of thiacetazone]., in Ann Dermatol Venereol, vol. 128, n. 12, Dic 2001, pp. 1305-7, PMID 11908132.
  • SA. Hussain, HC. Saksena; RP. Kothari, Stevens-Johnson syndrome due to thiacetazone., in J Indian Med Assoc, vol. 60, n. 2, Gen 1973, pp. 57-9, PMID 4123241.
  • MT. Dieng, B. Ndiaye; C. Camara, [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar]., in Dakar Med, vol. 46, n. 1, 2001, pp. 1-3, PMID 15773145.
  • VN. Ingle, Q. Banoo, Stevens-Johnson syndrome associated with administration of a combination of isonicotinic acid hydrazide and thiacetazone., in Indian Pediatr, vol. 2, n. 8, Ago 1965, pp. 305-7, PMID 4158699.
  • SP. Sahi, K. Chandra, Thiacetazone induced Steven-Johnson syndrome: a case report., in Indian J Chest Dis, vol. 16, n. 2, Apr 1974, pp. 124-5, PMID 4138166.
  • P. Blom, [Stevens-Johnson syndrome as a complication in tuberculosis treatment with thioacetazon]., in Ned Tijdschr Geneeskd, vol. 135, n. 52, Dic 1991, pp. 2492-3, PMID 1722029.
  • JJ. Wirima, AD. Harries, Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases., in East Afr Med J, vol. 68, n. 1, Gen 1991, pp. 64-6, PMID 2060484.
  • A. Okwera, JL. Johnson; MJ. Vjecha; K. Wolski; CC. Whalen; D. Hom; R. Huebner; RD. Mugerwa; JJ. Ellner, Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults., in Int J Tuberc Lung Dis, vol. 1, n. 5, Ott 1997, pp. 441-5, PMID 9441099.
  • CP. Theuer, PC. Hopewell; D. Elias; GF. Schecter; GW. Rutherford; RE. Chaisson, Human immunodeficiency virus infection in tuberculosis patients., in J Infect Dis, vol. 162, n. 1, Lug 1990, pp. 8-12, PMID 1972384.
  • PF. Barnes, AB. Bloch; PT. Davidson; DE. Snider, Tuberculosis in patients with human immunodeficiency virus infection., in N Engl J Med, vol. 324, n. 23, Giu 1991, pp. 1644-50, DOI:10.1056/NEJM199106063242307, PMID 2030721.
  • MR. Holdiness, Adverse cutaneous reactions to antituberculosis drugs., in Int J Dermatol, vol. 24, n. 5, Giu 1985, pp. 280-5, PMID 2410379.
  • MR. Holdiness, Neurological manifestations and toxicities of the antituberculosis drugs. A review., in Med Toxicol, vol. 2, n. 1, pp. 33-51, PMID 3547005.
  • WH. Jopling, Side-effects of antileprosy drugs in common use., in Lepr Rev, vol. 54, n. 4, Dic 1983, pp. 261-70, PMID 6199637.
  • Antileprosy drugs., in Br Med J, vol. 3, n. 5767, Lug 1971, pp. 174-6, PMID 4104273.

oadoi.org